Cancer Mechanisms Through The Lens Of Glycobiology Webinar Series (Registration)

Submitted by chancim on

Registration

Filling out this form registers you for all eight webinars in the series. After receiving the registration confirmation email, you will have the option to save the webinars to your calendar.

 

Your Information
Additional Registration Questions
Introductory session: Glycobiology & Cancer
Speaker: Carolyn Bertozzi, Ph.D., Stanford University
Overview: In this opening session, Dr. Carolyn Bertozzi will lay the groundwork for the seminar series by tracing the evolution of the field, assessing its current state, and highlighting the key biological questions that can be addressed through the lens of glycobiology in cancer research.
Moderator: Natalia Mercer, Ph.D.
Contribution of glycosylation to cancer cell proliferation and survival
Speaker: Brian Haab, Ph.D., Van Andel Institute & Manqi Zhang, Ph.D., Duke University
Overview: In tumors, how aberrant glycosylation contributes to increased proliferation and survival is not well understood, particularly in the context of stabilization of growth factor receptors, amplification of oncogenic signaling pathways, inhibition of receptor internalization, promotion of cell cycle progression, and suppression of programmed/non-programmed cell death.
Moderator: Ruibai Luo, Ph.D.
O-GlcNAcylation and transcriptional control in cancer
Speaker: Christina M. Woo, Ph.D., Harvard University & Mauricio Reginato, Ph.D., Drexel University
Overview: O GlcNAcylation is a dynamic post translational modification that affects a wide range of nuclear and cytoplasmic proteins, including transcription factors, histones, chromatin modifiers, and signaling proteins. Through these targets, O GlcNAcylation can influence transcriptional regulation and cell signaling. However, its specific role in shaping transcriptional programs and signaling pathways in cancer remains poorly defined. Addressing this gap is essential for understanding how O GlcNAc dependent regulation of transcription factors, histones, chromatin modifiers, and signaling proteins contributes to tumor initiation, progression, and therapeutic resistance.
Moderator: Zhihui Liu, Ph.D.
Glycoprotein-mediated immune modulation and implications for immunotherapy
Speaker: Virginia Shapiro, Ph.D., Mayo Clinic & Michael Demetriou, Ph.D, UC Irvine
Overview: This session will explore how glycoproteins function at the critical interface between tumor cells and the immune system, shaping immune recognition, signaling, and response to therapy. Drawing on advances in glycobiology and tumor immunology, the discussion will highlight how alterations in glycosylation regulate immune cell function, contribute to tumor immune evasion, and influence anti-tumor immunity. The session will also consider the potential of tumor-associated glycans as targets for cancer immunotherapy. Together, these perspectives will highlight the importance of glycoprotein-mediated interactions in cancer progression and identify opportunities to leverage these mechanisms to improve immunotherapeutic strategies.
Moderator: Monica Zamisch, Ph.D.
Glycocalyx – using complex carbohydrates to evade, invade, and metastasize
Speaker: Peggi Angel, Ph.D., MUSC & Mike Angelo, Ph.D., Stanford University
Overview: The glycocalyx, a dense layer of glycans, proteoglycans, and glycoproteins surrounding cells, is increasingly recognized as a dynamic regulator of metastasis, influencing tumor cell adhesion and migration, mechanosensing, immune interactions, and engagement with the extracellular matrix and vasculature. Gaps in knowledge exist in how glycocalyx remodeling differs across tumor types and metastatic sites, how specific glycans regulate cell–cell and cell–matrix interactions, and how the glycocalyx dynamically changes during each metastatic step and transition. Efforts to resolve cell-type and spatial heterogeneity and determine how glycan remodeling coordinates with immune and stromal niches have been spearheaded by Peggi Angel’s spatial MALDI imaging approaches and Mike Angelo’s highly multiplexed spatial profiling. Multimodal, spatially coregistered approaches could reveal actionable glycocalyx-dependent interactions during metastatic progression.
Moderator: Joanna Watson, Ph.D.
Bidirectional communication between cancer cells and their ecosystem mediated by glycans
Speaker: Susan Bellis, Ph.D., University of Alabama, Dannielle Engle Ph.D., Salk Institute & Kevin Tharp, Ph.D., Sanford Burnham Prebys
Overview: Glycans occupy a strategic position at the cell-environment interface and serve as essential components of the cellular ecosystem, including the extracellular matrix, secretome, and extracellular vesicles. Enhanced understanding of glyco-code decoding mechanisms will advance our comprehension of cell-TME communication during cancer progression and its contribution to tumor heterogeneity.
Moderator: Natalia Mercer, Ph.D.
Mapping glycans in cancer
Speaker: Kayvon Pedram, Ph.D., UC San Diego & Ramon Sun, Ph.D., University of Florida
Overview: Mapping glycans at single-cell resolution is challenging due to their complexity and diversity as well as requirement for extensive sample preparation. This seminar will discuss using complementary technologies in spatial metabolomics and advanced imaging to map glycans and study their roles in regulation of cellular metabolism. Dr. Sun could highlight spatial metabolomics approaches that map metabolic activity across tissues, while Dr. Pedram could present innovative imaging methods to study glycans and their regulatory roles. The seminar will demonstrate how integrating spatial metabolomics, chemical biology, imaging and computational tools could inform interactions between cellular metabolism and glycans that influence tumor progression and therapeutic response.
Moderator: Cindy Kyi Ph.D.
Shared glycobiology targets between viral infections and cancer
Speaker: Laura Kiessling, Ph.D., MIT & Chi-Huey Wong, Ph.D., Scripps Research
Overview: Several of our current understanding of cancer biology pathways and mechanisms stem from classical studies investigating viral infections. Growing evidence show that there are shared glycosylation patterns between cancer and viral infections. A deeper understanding of the glycobiology-associated changes during early viral infection could provide directions to understand early stages of tumor development and subsequently developing targeted approaches for cancer prevention/interception and treatment.
Moderator: Vignesh Gunasekharan, Ph.D.